Dr. Reddy's Laboratories
RDY
#1960
Rank
A$14.87 B
Marketcap
A$17.86
Share price
2.30%
Change (1 day)
-19.37%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2026 (TTM): A$0.75 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are A$3.61 Billion. In 2025 the company made an earning of A$1.24 Billion a decrease over its 2024 earnings that were of A$1.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.75 B-39.93%
2025 A$1.24 B-2.73%
2024 A$1.28 B7.01%
2023 A$1.20 B32.93%
2022 A$0.90 B26.77%
2021 A$0.71 B31.44%
2020 A$0.54 B54.54%
2019 A$0.35 B-14.21%
2018 A$0.40 B26.41%
2017 A$0.32 B4.47%
2016 A$0.30 B-55.7%
2015 A$0.69 B1.83%
2014 A$0.68 B-3.78%
2013 A$0.71 B54.07%
2012 A$0.46 B-16.23%
2011 A$0.55 B56.66%
2010 A$0.35 B-235.36%
2009 -A$0.27 Billion-198.53%
2008 A$0.26 B30.77%
2007 A$0.20 B-14.61%
2006 A$0.23 B703.63%
2005 A$29.47 M649.45%
2004 A$3.93 M-95.68%
2003 A$90.95 M-14.86%
2002 A$0.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.21 B 2,984.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$9.88 B 1,272.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.24 B 1,322.79%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
A$11.29 B 1,467.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$2.29 B 218.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel